StockDrifts LogoStockDrifts

Boxer Capital Management 13F Portfolio

Portfolio Manager
Boxer Capital Management LLC
Performance
+37.58% (2026 Q2)
AUM (13F)
$1.33B
# of Holdings
63
Performance Rank
N/A
Allocation (Top 20)
82.4%
Latest filing
Q2 2026

Boxer Capital Management LLC Holdings Map

Top 50 Boxer Capital Management LLC Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
TNGX
TANGO THERAPEUTICS INC
25.61%10.88M$340.0M
+0.00%(+0)
2025-Q2: 9.77M shares2025-Q3: 9.77M shares2025-Q4: 10.88M shares2026-Q1: 10.88M shares2026-Q2: 10.88M shares
$5.72(+347.27%)
2026-06-30
RVMD
REVOLUTION MEDICINES INC
7.05%500.0K$93.6M
+0.00%(+0)
2025-Q2: 793.0K shares2025-Q3: 400.0K shares2025-Q4: 400.0K shares2026-Q1: 500.0K shares2026-Q2: 500.0K shares
$53.33(+282.01%)
2026-06-30
ABVX
ABIVAX SA
6.07%605.0K$80.6M
+202.50%(+405.00K)
2025-Q2: 0 shares2025-Q3: 120.0K shares2025-Q4: 125.0K shares2026-Q1: 200.0K shares2026-Q2: 605.0K shares
$103.92(+14.47%)
2026-06-30
QURE
UNIQURE NV
5.21%1.50M$69.2M
+127.08%(+841.30K)
2025-Q2: 899.5K shares2025-Q3: 800.0K shares2025-Q4: 290.0K shares2026-Q1: 662.0K shares2026-Q2: 1.50M shares
$24.23(+100.63%)
2026-06-30
KOD
KODIAK SCIENCES INC
4.34%1.48M$57.6M
+8.57%(+116.60K)
2025-Q2: 750.0K shares2025-Q3: 750.0K shares2025-Q4: 1.14M shares2026-Q1: 1.36M shares2026-Q2: 1.48M shares
$16.88(+145.02%)
2026-06-30
KYMR
KYMERA THERAPEUTICS INC
3.71%429.1K$49.2M
+30.39%(+100.00K)
2025-Q2: 432.0K shares2025-Q3: 319.1K shares2025-Q4: 329.1K shares2026-Q1: 329.1K shares2026-Q2: 429.1K shares
$55.43(+111.78%)
2026-06-30
DFTX
DEFINIUM THERAPEUTICS INC
3.54%998.5K$47.0M
+66.83%(+400.00K)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 598.5K shares2026-Q2: 998.5K shares
$22.60(+88.59%)
2026-06-30
REPL
REPLIMUNE GROUP INC
3.32%3.98M$44.1M
+238.98%(+2.81M)
2025-Q2: 2.21M shares2025-Q3: 1.05M shares2025-Q4: 750.0K shares2026-Q1: 1.18M shares2026-Q2: 3.98M shares
$9.48(+57.93%)
2026-06-30
CELC
CELCUITY INC
3.28%416.5K$43.6M
+85.12%(+191.53K)
2025-Q2: 0 shares2025-Q3: 90.0K shares2025-Q4: 225.0K shares2026-Q1: 225.0K shares2026-Q2: 416.5K shares
$79.89(+15.15%)
2026-06-30
QTTB
Q32 BIO INC
3.02%3.15M$40.1Mnew2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 0 shares2026-Q1: 0 shares2026-Q2: 3.15M shares
$9.32(+62.55%)
2026-06-30

About Boxer Capital Management LLCโ€™s portfolio

Boxer Capital Management LLC reports $1.33B in US-listed equity holdings across 63 positions in its most recent 13F filing. Its largest disclosed positions are TNGX (25.6%), RVMD (7.0%) and ABVX (6.1%). The top 20 holdings account for 82.4% of reported assets. Its disclosed equity book has returned +229.85% cumulatively over 6 quarters. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
TNGX โ€” 26.1% ($339.99M)RVMD โ€” 7.2% ($93.64M)ABVX โ€” 6.2% ($80.62M)QURE โ€” 5.3% ($69.24M)KOD โ€” 4.4% ($57.57M)KYMR โ€” 3.8% ($49.20M)DFTX โ€” 3.6% ($46.97M)REPL โ€” 3.4% ($44.09M)CELC โ€” 3.3% ($43.58M)QTTB โ€” 3.1% ($40.12M)Other โ€” 33.7% ($439.02M)
66%in top 10
  • TNGX26.1%
  • RVMD7.2%
  • ABVX6.2%
  • QURE5.3%
  • KOD4.4%
  • KYMR3.8%
  • DFTX3.6%
  • REPL3.4%
  • CELC3.3%
  • QTTB3.1%
  • Other33.7%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

New buys
9
QTTBQ32 BIO INC3.0%
SYRESPYRE THERAPEUTICS INC0.7%
RLAYRELAY THERAPEUTICS INC0.6%
KZIAKAZIA THERAPEUTICS LTD0.6%
+5 opened
Added to
17
ABVXABIVAX SA+202.5%
QUREUNIQURE NV+127.1%
REPLREPLIMUNE GROUP INC+239.0%
CELCCELCUITY INC+85.1%
+13 more
Trimmed
1
ALLOALLOGENE THERAPEUTICS INC-45.0%

Unlock alerts, watchlists & AI chat

Sign up free to track Boxer Capital Management LLC, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from Boxer Capital Management LLCโ€™s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 2018299). View Boxer Capital Management LLCโ€™s 13F filings on SEC

More 13F analyses

View all